Medunik Canada und Lucane Pharma unterzeichnen Lizenz- und Kooperationsvereinbarung zur Behandlung kanadischer Patienten mit Störungen des Harnstoffzyklus, einer Gruppe seltener Erbkrankheiten

News provided by

Médunik Canada

Dec 04, 2013, 15:51 ET

BLAINVILLE, Québec, December 4, 2013 /PRNewswire/ --

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Also from this source

Médunik Canada and the Population Council join in a research partnership for a potential new treatment for multiple sclerosis

Médunik Canada and the Population Council join in a research partnership for a potential new treatment for multiple sclerosis

If proven safe and effective throughout the remaining stages of research, segesterone acetate (SGA) could be one of the first remyelination therapies ...
More Releases From This Source

Explore

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Joint Ventures

Joint Ventures

News Releases in Similar Topics